Mark Leschly, Director, 10% Owner at Anacor Pharmaceuticals Inc (ANAC), bought 2,907,398 shares at $5.00 ($12.0M) on 2010-11-30, disclosed to the SEC on 2010-12-01.
Open-market purchase of $12.0M ANAC by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 507,398 | $0 | 0.0% |
| 2 | $5.00 | 2,400,000 | $12.0M | 100.0% |
| Total | $4.13 avg | 2,907,398 | $12.0M | 100% |
| Filing → |
| CARA | BUY | 2014-02-05 | $2.5M | — | Filing → |
| BFLY | BUY | 2012-11-15 | $299K | — | Filing → |
| AVNC | BUY | 2007-04-16 | $2.8M | — | Filing → |